Skip to content

uniQure QURE Stock-Based Comp

Stock-Based Comp at other companies

Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
$23.09M-8.2%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$23.42M+29.7%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$16.32M-19.2%
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
$13.61M+1.0%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$17.16M+54.2%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$33.24M+28.4%

Segments

By segment

See full
Single Reportable$5.09M+15.4%

Other financials

Income statement

See full
Revenue$3.6M+127%
Gross profit$3.3M+144%
Operating income-$45.7M-16.2%
Net income-$53.5M-22.7%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$140.0M-35.6%
Total debt$63.3M-4.3%
Total equity$149.3M+343%
Total assets$778.7M+28.6%

Cash flow

See full
Operating cash flow-$38.2M+13.3%
CapEx$140.0K+11.1%
Free cash flow-$38.4M+13.2%

Valuation

See full
Market cap$3.09B+78.4%
Enterprise value$3.02B+124%
P/S170.9×+85.1×

Profitability

See full
Gross margin90.6%-2.9pp
Operating margin-1,059.7%+380pp
Net margin-1,154.4%+89.3pp
FCF margin-953.7%+169pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.4×-1.5×
Current ratio10.4×-1.6×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: uniQure’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about uniQure's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is uniQure's stock-based comp?
uniQure (QURE) reported stock-based comp of $5.09M in Q1 2026.
How has uniQure's stock-based comp changed year-over-year?
uniQure's stock-based comp increased by 15.4% year-over-year, from $4.41M to $5.09M.
What is the long-term trend for uniQure's stock-based comp?
Over 4 years (2021 to 2025), uniQure's stock-based comp has grown at a -8.9% compound annual growth rate (CAGR), from $25.64M to $17.68M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.